🇺🇸 FDA
Patent

US 10201596

Peptide conjugated particles for the treatment of allergy

granted A61KA61K2039/55555A61K2039/577

Quick answer

US patent 10201596 (Peptide conjugated particles for the treatment of allergy) held by Northwestern University expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/55555, A61K2039/577, A61K2039/6093, A61K39/0005